Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,402.00p
   
  • Change Today:
      38.00p
  • 52 Week High: 3,170.00
  • 52 Week Low: 1,924.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 172,753
  • Market Cap: £1,598.28m
  • RiskGrade: 128
  • Beta: 0.01
Select chart: 3 month | 6 month | 1 year
 

3 month

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 708.07 95.29 100.59p 23.9 n/a n/a 33.08p 0.0%
30-Jun-27 734.49 98.41 105.69p 22.7 4.5 +5% 35.69p 0.0%
30-Jun-28 768.36 105.96 114.94p 20.9 2.4 +9% 36.35p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
30-Jun-2026 n/a n/a n/a 708 n/a 702
30-Jun-2027 n/a n/a n/a 734 n/a 740
30-Jun-2028 n/a n/a n/a 768 n/a n/a
 
Earnings
30-Jun-2026 n/a n/a n/a 100.72p n/a 89.07p
30-Jun-2027 n/a n/a n/a 105.89p n/a 100.81p
30-Jun-2028 n/a n/a n/a 115.16p n/a n/a
 
Dividend
30-Jun-2026 n/a n/a n/a 33.08p n/a 34.60p
30-Jun-2027 n/a n/a n/a 35.69p n/a 35.36p
30-Jun-2028 n/a n/a n/a 36.35p n/a n/a
 
Recommendations
Strong Buy 0 0 0 6 4 0
Buy 0 0 0 2 2 0
Neutral 0 0 0 2 1 0
Sell 0 0 0 0 1 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 0 0 0 10 8 0
 
Average Rec n/a n/a n/a 8.50 7.81 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,402.00p
Change Today 38.00p
% Change 1.61 %
52 Week High 3,170.00
52 Week Low 1,924.00
Volume 172,753
Shares Issued 66.54m
Market Cap £1,598.28m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 2
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Mar-26 06-Nov-25
Paid 27-Mar-26 05-Dec-25
Amount 11.20p 21.70p

Trades for 15-May-2026

Time Volume / Share Price
16:37 26,000 @ 2,379.92p
16:50 2,049 @ 2,388.92p
16:47 716 @ 2,379.59p
16:37 26,000 @ 2,379.92p
16:35 49,175 @ 2,402.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page